Page 117
|
|
|
Page 117 |
The regulation of vaccines, serums, and other biologic products, which includes the establishment of product standards and the licensing of manufacturers, previously carried out by the National Institutes of Health was transferred to the FDA's Bureau of Biologics in 1972, and in 1987 to the FDA's Center for Biologics Evaluation and Research which became responsible for the continued safety, purity, potency, and efficacy of these products.
c. 1980
Page:
5 10 15
20 25 30
35 40 45
50 55 60
65 70 75
80 85 90
95 100
105 110
115 120
125 130
135 140
145 150
155 160
165 170
Images from the History of Public Health Service Home Page
Exhibition and Public Programs Home Page
History of Medicine Home Page
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health Department of Health & Human Services Copyright, Privacy, Accessibility Last updated: 27 April 1998 |